Article Sidebar

PDF
Date Published: 25/04/2024
Online Published: 25/04/2024
Abstract Views: 25
Views PDF: 15
DOI: https://doi.org/10.58490/ctump.2024i73.2459
Issue
No. 73 (2024)
Section
Article
How to Cite
Doan, V. D., Nguyen, T. H. Y., Tra, L. T. V., Nguyen, T. T. H., Nguyen, H. N., Ngo, K. T., & Nguyen, V. G. (2024). SURVEY RECENT INFECTIONS INCIDENCE AMONG INDIVIDUALS WITH A NEW HIV DIAGNOSIS AT CAN THO CITY – CENTER FOR DESEASE CONTROL IN 2023. Cantho Journal of Medicine and Pharmacy, 73, 31-37. https://doi.org/10.58490/ctump.2024i73.2459

SURVEY RECENT INFECTIONS INCIDENCE AMONG INDIVIDUALS WITH A NEW HIV DIAGNOSIS AT CAN THO CITY – CENTER FOR DESEASE CONTROL IN 2023

Van Dien Doan1,, Thi Hai Yen Nguyen2, Lam Tuan Vu Tra1, Thi Thanh Huyen Nguyen1, Hong Ngoc Nguyen2, Kim Tu Ngo2, Van Giem Nguyen2
1 Can Tho city - Center for Desease Control
2 Can Tho University of Medicine and Pharmacy

Main Article Content

Abstract

Background: Recent tests can distinguish recent in the prior 12 months from long-term HIV infection through integrating serological tests with viral load. Objectives: To determine the incidence of HIV among HIV patients with a new HIV diagnosis at Can Tho city - Center for desease Control in 2023. Materials and methods: Descriptive method through cross-sectional survey HIV patients ≥ 16 years old with a new HIV diagnosis. Results: The study showed that 18.8% of participants recency HIV of which 11.8% were living and working in Can Tho. Factors independently associated with HIV recency was student (OR = 3.29). Conclusions: The rate ofHIV recency is high. Factors independently associated with HIV  recency isstudent. 

Article Details

Keywords

HIV Recency, RITA, Can Tho City

References

1. Hartana C. A., Yu X. G. Immunological effector mechanisms in HIV-1 elite controllers. Curr Opin HIV AIDS. 2021. 16(5), 243-248, doi: 10.1097/COH.0000000000000693.
2. Sedia Biosciences Corporation. AsanteTM HIV-1 Rapid Recency Assay. Sedia Biosciences Corporation Beaverton, Oregon USA. 2022.
3. Kim A. A., Behel S., Northbrook S., Parekh B. S. Tracking with recency assays to control the epidemic: real-time HIV surveillance and public health response. AIDS. 2019. 33(9), 15271529, doi: 10.1097/QAD.0000000000002239.
4. Rwibasira G. N., Malamba S. S., Musengimana G., Nkunda R. C. M., Omolo J. et al. Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018-2020. PLoS One. 2021. 16(11), doi: 10.1371/journal.pone.0259708.
5. Thủ Tướng Chính Phủ. Quyết định số 1246/QĐ-TTg ngày 14 tháng 8 năm 2020 của Thủ tướng chính phủ về việc phê duyệt Chiến lược Quốc gia chấm dứt dịch bệnh AIDS vào năm 2030. Hà Nội. 2020.
6. UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2014, doi: 10.1152/ajplegacy.1975.229.3.570.
7. Agyemang E. A., Kim A. A., Dobbs T., Zungu I., Payne D. et al. Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018. PLoS One. 2022. 17(2), e0262071, doi: 10.1371/journal.pone.0262071.
8. Aghaizu A., Murphy G., Tosswill J., DeAngelis D., Charlett A. et al. Recent infection testing algorithm (RITA) applied to new HIV diagnoses in England, Wales and Northern Ireland, 2009 to 2011. Euro Surveill. 2014. 19(2), doi: 10.2807/1560-7917.es2014.19.2.20673.
9. Tang X. J., Duan L. J., Liang W. L., Cheng S., Dong T. L. et al. Application of limiting antigen avidity enzyme immunoassay for estimating HIV-1 incidence in men who have sex with men. Zhonghua Liu Xing Bing Xue Za Zhi. 2022. 43(1), 72-77, doi: 10.3760/cma.j.cn11233820210609-00463.
10. Welty S., Motoku J., Muriithi C., Rice B., de Wit M. et al. Brief Report: Recent HIV Infection Surveillance in Routine HIV Testing in Nairobi, Kenya: A Feasibility Study. J Acquir Immune Defic Syndr. 2020. 84(1), 5-9, doi: 10.1097/QAI.0000000000002317.
11. Dacus J. D., Sandfort T. G. M. Perceived HIV Risk Among Black MSM Who Maintain HIVNegativity in New York City. AIDS Behav. 2020. 24(11), 3044-3055, doi: 10.1007/s10461020-02852-y.
12. Li Q. H., Wang J. Y., Liu S. Y., Zhang Y. Q., Li E. L. et al. Young MSM changed temporal HIV-1 epidemic pattern in Heilongjiang Province, China. Front Microbiol. 2022. 13, 1028383, doi: 10.3389/fmicb.2022.1028383.
13. Wang Y., Tanuma J., Li J., Iwahashi K., Peng L. et al. Elimination of HIV transmission in Japanese MSM with combination interventions. Lancet Reg Health West Pac. 2022. 23, 100467, doi: 10.1016/j.lanwpc.2022.100467.